全文获取类型
收费全文 | 1648篇 |
免费 | 125篇 |
国内免费 | 1篇 |
出版年
2023年 | 7篇 |
2022年 | 25篇 |
2021年 | 52篇 |
2020年 | 24篇 |
2019年 | 29篇 |
2018年 | 36篇 |
2017年 | 50篇 |
2016年 | 56篇 |
2015年 | 70篇 |
2014年 | 86篇 |
2013年 | 136篇 |
2012年 | 161篇 |
2011年 | 115篇 |
2010年 | 85篇 |
2009年 | 74篇 |
2008年 | 75篇 |
2007年 | 79篇 |
2006年 | 75篇 |
2005年 | 79篇 |
2004年 | 67篇 |
2003年 | 51篇 |
2002年 | 51篇 |
2001年 | 19篇 |
2000年 | 18篇 |
1999年 | 11篇 |
1998年 | 15篇 |
1997年 | 7篇 |
1996年 | 9篇 |
1995年 | 6篇 |
1993年 | 8篇 |
1992年 | 11篇 |
1991年 | 11篇 |
1990年 | 14篇 |
1989年 | 10篇 |
1988年 | 14篇 |
1987年 | 9篇 |
1986年 | 11篇 |
1985年 | 9篇 |
1983年 | 9篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 7篇 |
1976年 | 7篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1972年 | 7篇 |
1971年 | 5篇 |
排序方式: 共有1774条查询结果,搜索用时 15 毫秒
991.
992.
During protein synthesis, tRNA serves as the intermediary between cognate amino acids and their corresponding RNA trinucleotide codons. Aminoacyl-tRNA is also a biosynthetic precursor and amino acid donor for other macromolecules. AA-tRNAs allow transformations of acidic amino acids into their amide-containing counterparts, and seryl-tRNASer donates serine for antibiotic synthesis. Aminoacyl-tRNA is also used to cross-link peptidoglycan, to lysinylate the lipid bilayer, and to allow proteolytic turnover via the N-end rule. These alternative functions may signal the use of RNA in early evolution as both a biological scaffold and a catalyst to achieve a wide variety of chemical transformations. 相似文献
993.
994.
Neeraj Maheshwari Satish Kantipudi Anand Maheshwari Kashika Arora Vandana Neha Kwatra Girish Sahni 《PloS one》2016,11(3)
Streptokinase (SK) is a potent clot dissolver but lacks fibrin clot specificity as it activates human plasminogen (HPG) into human plasmin (HPN) throughout the system leading to increased risk of bleeding. Another major drawback associated with all thrombolytics, including tissue plasminogen activator, is the generation of transient thrombin and release of clot-bound thrombin that promotes reformation of clots. In order to obtain anti-thrombotic as well as clot-specificity properties in SK, cDNAs encoding the EGF 4,5,6 domains of human thrombomodulin were fused with that of streptokinase, either at its N- or C-termini, and expressed these in Pichia pastoris followed by purification and structural-functional characterization, including plasminogen activation, thrombin inhibition, and Protein C activation characteristics. Interestingly, the N-terminal EGF fusion construct (EGF-SK) showed plasmin-mediated plasminogen activation, whereas the C-terminal (SK-EGF) fusion construct exhibited ‘spontaneous’ plasminogen activation which is quite similar to SK i.e. direct activation of systemic HPG in absence of free HPN. Since HPN is normally absent in free circulation due to rapid serpin-based inactivation (such as alpha-2-antiplasmin and alpha-2-Macroglobin), but selectively present in clots, a plasmin-dependent mode of HPG activation is expected to lead to a desirable fibrin clot-specific response by the thrombolytic. Both the N- and C-terminal fusion constructs showed strong thrombin inhibition and Protein C activation properties as well, and significantly prevented re-occlusion in a specially designed assay. The EGF-SK construct exhibited fibrin clot dissolution properties with much-lowered levels of fibrinogenolysis, suggesting unmistakable promise in clot dissolver therapy with reduced hemorrhage and re-occlusion risks. 相似文献
995.
996.
R. K. Anand 《BMJ (Clinical research ed.)》1996,312(7046):1556-1557
997.
998.
999.
1000.